Effect of ZnO addition on bioactive CaO-SiO2-P2O5-CaF2 glass-ceramics containing apatite and wollastonite

被引:63
作者
Kamitakahara, M
Ohtsuki, C
Inada, H
Tanihara, M
Miyazaki, T
机构
[1] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan
[2] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan
关键词
glass-ceramics; bioactivity; apatite; zinc; simulated body fluid;
D O I
10.1016/j.actbio.2006.03.001
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Some ceramics show bone-bonding ability, i.e. bioactivity. Apatite formation on ceramics is an essential condition to bring about direct bonding to living bone when implanted into bony defects. A controlled surface reaction of the ceramic is an important factor governing the bioactivity and biodegradation of the implanted ceramic. Among bioactive ceramics. glass-ceramic A-W containing apatite and wollastonite shows high bioactivity, as well as high mechanical strength. In this study. glass-ceramics containing zinc oxide were prepared by modification of the composition of the glass-ceramic A-W. Zinc oxide was selected to control the reactivity of the Glass-ceramics since zinc is a trace element that shows stimulatory effects on bone formation. Glass-ceramics were prepared by heat treatment of glasses with the general composition: xZnO . (57.0 - x)CaO . 35ASiO(2) . 7.2P(2)O(5) . 0.4CaF(2) (where x = 0-14.2 mol.%). Addition of ZnO increased the chemical durability of the glass-ceramics, resulting in a decrease in the rate of apatite formation in a simulated body fluid. On the other hand, the release of zinc from the glass-ceramics increased with increasing ZnO content. Addition of ZnO may provide bioactive CaO-SiO2-P2O5-CaF, glass-ceramics with the capacity for appropriate biodegradation. as well as enhancement of bone formation. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:467 / 471
页数:5
相关论文
共 17 条
[1]   DEPENDENCE OF APATITE FORMATION ON SILICA-GEL ON ITS STRUCTURE - EFFECT OF HEAT-TREATMENT [J].
CHO, SB ;
NAKANISHI, K ;
KOKUBO, T ;
SOGA, N ;
OHTSUKI, C ;
NAKAMURA, T ;
KITSUGI, T ;
YAMAMURO, T .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1995, 78 (07) :1769-1774
[2]  
Hench L.L., 1971, Journal of Biomedical Materials Research Symposium, V36, P117, DOI DOI 10.1002/JBM.820050611
[3]   BIOCERAMICS - FROM CONCEPT TO CLINIC [J].
HENCH, LL .
JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1991, 74 (07) :1487-1510
[4]  
Hulbert S.F., 1993, Adv. Ser. Ceram., V1, P25
[5]  
Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.3.CO
[6]  
2-X
[7]  
JARCHO M, 1977, J BIOENG, V1, P79
[8]  
Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
[9]   SOLUTIONS ABLE TO REPRODUCE INVIVO SURFACE-STRUCTURE CHANGES IN BIOACTIVE GLASS-CERAMIC A-W3 [J].
KOKUBO, T ;
KUSHITANI, H ;
SAKKA, S ;
KITSUGI, T ;
YAMAMURO, T .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (06) :721-734
[10]   CA, P-RICH LAYER FORMED ON HIGH-STRENGTH BIOACTIVE GLASS-CERAMIC A-W [J].
KOKUBO, T ;
ITO, S ;
HUANG, ZT ;
HAYASHI, T ;
SAKKA, S ;
KITSUGI, T ;
YAMAMURO, T .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (03) :331-343